Chemours Appoints Matthew Conti as Chief Human Resources Officer

Seasoned HR executive supports Chemours’ Pathway to Thrive strategy

The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM), today announced the appointment of Matthew Conti as Chief Human Resources Officer (CHRO), effective June 2. His appointment follows an extensive external search to identify a leader who will drive Chemours’ people and culture strategy.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612880421/en/

Chemours appoints Matthew Conti as Chief Human Resources Officer

In this role, Conti will lead Chemours’ global human resources organization, overseeing talent strategy, organizational development, employee engagement, and culture initiatives. He will play a pivotal role in advancing the company’s Pathway to Thrive strategy by aligning human capital priorities with business objectives and fostering a high-performing culture.

“Matthew’s appointment comes at a critical time as we continue to evolve our culture and capabilities to meet the demands of our stakeholders and the opportunities ahead,” said Denise Dignam, President and CEO of Chemours. “His deep expertise in global manufacturing environments and his people-first leadership style will help us build a more agile, values-based and high-performing organization.”

“I’m honored to join Chemours at such a pivotal moment in its journey,” said Conti. “I look forward to partnering with our teams to build a culture that empowers people, accelerates innovation, and drives sustainable growth.”

Conti brings over two decades of HR leadership experience across global manufacturing, specialty chemicals, and industrial sectors. Most recently, he served as CHRO at Vantage Specialty Chemicals, where he led enterprise-wide transformation initiatives. He has also held senior roles at Ingredion Corporation and Precision Castparts Corporation, where he built scalable talent systems and supported complex global operations.

Conti holds a Bachelor of Arts in Economics from Kalamazoo College and an MBA from the London Business School. He will be based at Chemours’ global headquarters in Wilmington, Delaware, and serve as a key member of the Executive Team.

About The Chemours Company

The Chemours Company (NYSE: CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through our three businesses – Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials – we deliver application expertise and chemistry-based innovations that solve customers’ biggest challenges. Our flagship products are sold under prominent brands such as Opteon™, Freon™, Ti-Pure™, Nafion™, Teflon™, Viton™, and Krytox™. Headquartered in Wilmington, Delaware and listed on the NYSE under the symbol CC, Chemours has approximately 6,000 employees and 28 manufacturing sites and serves approximately 2,500 customers in approximately 110 countries. For more information, visit chemours.com or follow us on LinkedIn.

Forward-Looking Statements

This press release contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical or current fact. The words "believe," "expect," "will," "anticipate," "plan," "estimate," "target," "project" and similar expressions, among others, generally identify "forward-looking statements," which speak only as of the date such statements were made. These forward-looking statements may address, among other things, Company performance or growth, the Company’s refreshed corporate strategy all of which are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These statements are not guarantees of future performance. Forward-looking statements also involve risks and uncertainties that are beyond Chemours' control. Matters outside our control, including general economic conditions, geopolitical conditions, changes in laws and regulations in the U.S. or other jurisdictions in which we operate, global health and weather events, have affected or may affect our business and operations and may or may continue to hinder our ability to provide goods and services to customers, cause disruptions in our supply chains such as through strikes, labor disruptions or other events, adversely affect our business partners, significantly reduce the demand for our products, adversely affect the health and welfare of our personnel or cause other unpredictable events. Additionally, there may be other risks and uncertainties that Chemours is unable to identify at this time or that Chemours does not currently expect to have a material impact on its business. Factors that could cause or contribute to these differences include the risks, uncertainties and other factors discussed in our filings with the U.S. Securities and Exchange Commission, including in our Annual Report on Form 10-K for the year ended December 31, 2024 and our Quarterly Report on Form 10-Q for the quarter ended March 31, 2025. Chemours assumes no obligation to revise or update any forward-looking statement for any reason, except as required by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250612880421/en/

“I’m honored to join Chemours at such a pivotal moment in its journey. I look forward to partnering with our teams to build a culture that empowers people, accelerates innovation, and drives sustainable growth,” said Matthew Conti, CHRO at Chemours.